In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus

BMC Complementary and Alternative Medicine

Volumn 6, Issue , 2006, Pages

  Mani, Sachin ^a   Lawson, John W ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLYCOGEN; HYDROCHLORIC ACID; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 2; NATURAL PRODUCT; POLYSORBATE 20; PROSTAGLANDIN SYNTHASE; TISSUE EXTRACT; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CYTOKINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MUSSEL; NONHUMAN; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; B LYMPHOCYTE; DRUG EFFECT; HYBRIDOMA; LYMPHOCYTE; METABOLISM; PERNA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; HYBRIDOMAS; IMMUNOGLOBULIN G; LYMPHOCYTES; PERNA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TISSUE EXTRACTS;

EID: 33644657060     PISSN: 14726882     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-6-1     Document Type: Article

References (53)

1. Wernick R, Campbell SM: Update in rheumatology. Annals of Internal Medicine 2000, 132:125-133.
2. Szobor A, Mattyus A, Molnar J: Myasthenia gravis in childhood and adolescence. Report on 209 patients and review of the literature. Acta Paediatrica Hungarica 1988, 29:299-312.
3. Smiley JD, Moore SEJ: Molecular mechanisms of autoimmunity. American Journal of Medical Science 1988, 295:478-496.
4. Mihara M, Ohsugi Y, Saito K, Miyal T, Togashi M, Ono S, Murakami S, Dobashi K, Hirayama F, Hamaoka T: Immunologic abnormality in NZB/NZW FI mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals. Journal of Immunology 1988, 141:85-90.
5. Kloke T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987, 36:539-541.
6. Hang L, Theofilopoulos AN, Dixon FJ: A spontaneous rheumatoid arthritis-like disease in MRL/I mice. Journal of Experimental Medicine 1982, 155:1690-1701.
7. Balkwill FR, Burke F: The cytokine network. Immunology Today 1989, 10:299-304.
8. Dean GS, Tyrell-Price J, Crawley E. Isenberg DA: Cytokines and systemic lupus erythematosus. Annals of Rheumatic Diseases 2000, 59:243-251.
9. Badolato R, Oppenheim JJ: Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthrits. Seminars in Arthritis and Rheumatology 1996, 26:526-538.
10. Paolieri F, Salmaso C, Battifora M, Montagna P, Pesce G, Bagnasco M, Richiusa P, Galluzzo A, Giordano C: Possible pathogenetic relevance of interleukin-I beta in "destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis). Annals of the New York Academy of Sciences 1999, 876:221-228.
11. Pelletier JP, Roughley PJ, DiBattista JA, McCollum R, Martel-Pelletier J: Are cytokines involved in osteoarthritic pathophysiology? Seminars in Arthritis and Rheumatism 1991, 20:12-25.
12. Miller TE, Ormrod D: The anti-inflammatory activity of Perna canaliculus (NZ green lipped mussel). The New Zealand Medical Journal 1980, 92:187-193.
13. Gibson RG, Gibson SL, Conway V, Chappell D: Perna canaliculus in the treatment of arthritis. Practitioner 1980, 224:955-960.
14. Gibson SL, Gibson RG: The treatment of arthritis with a lipid extract of Perna canaliculus: a random trial. Complementary Therapies in Medicine 1998, 6:122-126.
15. Andeuval B, Bochacourt P: Controlled double-blind study of the mussel extract Perna canaliculus (green-lipped mussel) against a placebo in arthritis of the knee. Gazette Medicale 1986, 93:122-126 (French).
16. Huskisson EC, Scott J, Bryans R: Seatone is ineffective in rheumatoid arthritis. British Medical Journal 1981, 282:1358-1359.
17. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for asprin-like drugs. Nature New Biology 1971, 231:232-235.
18. Miller TE, Wu H: In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract. The New Zealand Medical Journal 1984, 97:355-357.
19. Ferreira SH, Vane JR: New aspects of the mode of action of non-steroidal anti-inflammatory drugs. Annual Review of Pharmacology 1974, 14:57-73.
20. Kosuge T, Tsuji K, Ishida H, Yamaguchi T: Isolation of an anti-histaminic substance from green-lipped mussel (Perna canaliculus). Chem Pharm Bull (Tokyo) 1986, 34:4825-4828.
21. Whitehouse MW, Macrides TA, Kalafatis N, Betts WA, Haynes DR, Bradbert J: Anti-inflamatory activity of a lipid fraction (Lyprinol) from New Zealand green-lipped mussel. Inflammopharmacology 1997, 5:237-246.
22. Miller TE, Dodd J, Ormrod DJ, Geddes R: Anti-inflammatory activity of glycogen extracted from Perna canaliculus (NZ green-lipped mussel). Agents Actions 1993, 38 Spec No:C139-42.
23. Caughey DE, Grigor RR, Caughey EB, Young P, Gow PJ, Stewart AW: Perna canaliculus in the treatment of rheumatoid arthritis. Eur J Rheumatol Inflamm 1983, 6:197-200.
24. Couch RA, Ormrod DJ, Miller TE, Watkins WB: Anti-inflammatory activity in fractionated extracts of the green-lipped mussel. The New Zealand Medical Journal 1982, 95:803-806.
25. House RV: Cytokine bioassays: an overview. Developments in Biological Standardization 1999, 97:13-19.
26. Thorpe R, Wadhwa M, Page C, Mire-Sluis A: Bioassays for the characterization and control of theapeutic cytokines; determination of potency. Developments in Biological Standardization 1999, 97:61-71.
27. Mire-Sluis AR, Page L, Thorpe R: Quantitative cell line based bioassays for human cytokines. Journal of Immunological Methods 1995, 187:191-199.
28. Thorpe R, Wadhwa M, Bird CR, Mire-Sluis AR: Detection and measurment of cytokines. Blood Reviews 1992, 6:133-148.
29. Tomkins P, Wadhwa M, Bird CR, Bowen G: The L929 cell bioassay for maurine tumor necrosis factor is not influenced by other murine cytokines. Journal of Immunological Methods 1992, 151:313-315.
30. Hay H, Cohen J: Studies on the specificity of the L929 cell bioassay for the measurement of tumour necrosis factor. Journal of Clinical and Laboratory Immunology 1989, 29: 151-155.
31. Kelsari Y: A colorimetric microtiter assay for the quantitation cytokine activity on adherent cells in tissue culture. Journal of Immunological Methods 1992, 146:155-161.
32. Gieni RS, Li Y, HayGlass KT: Comparison of [3H] thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. Journal of immunological Methods 1995, 187:85-83.
33. Goto M, Kirisawa R, Tajima M, Takahashi K, Iwai H: A bioassay for bovine interleukin-I by the A375 cell inhibition. Journal of Vetrinary Medical Science 1995, 57:523-525.
34. Nakai S, Mizuno K, Kaneta M, Hirai Y: A simple, sensitive bioassay for the detection of interleukin-I using human melanoma A375 cell line. Biochemical Biophysical Research Communications 1988, 154:541-548.
35. Pruett SB, Lackey A, Howell B, Ainsworth J: A quantitative, non-isotopic bioassay for inteleukin 2. Immunological Investigation 1985, 14:541-548.
36. Cernetti C, Steinman RM, Granelli-Piperno A: Bioassays for the detection of a cytokine that enhance the defelopment of cytolytic T lymphocytes. Cellular Immunology 1987, 109:148-158.
37. Pruett SB, Lackey A: Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells. Clinical and Experimental Immunology 1987, 69:624-631.
38. Eskandari MK, Kunkel SL, Remick DG: Effects of arachidonic acid metabolites and other compounds on the CTLL assay for interleukin-2. Journal of Immunological Methods 1989, 118:85-99.
39. Papadopoulos NG, Dedoussis GV, Baxevanis CN, Papamichail M: Bioassay vs. immunoassay for quantification of interleukin-6 in biological fluids. Journal of Clinical Laboratory Analysis 1995, 9:234-237.
40. Liu J, Li H, de Tribolet N, Jaufeerally R, Hamou MF, Van Meir EG: IL-6 stimulates growth and Inhibits constitutive, protein synthesis-independent apoptosis of maurine B-cell hypridoma 7TDI. Cellular Immunology 1994, 155:428-435.
41. Krakauer T: A sensitive, specific immunobioassay for quantitation of human interleukin 6. Journal of Immunaassay 1993, 14:267-277.
42. Slim GC: Extracting glycogen from green shell mussels and the use of the glycogen as a food supplement or additive or in the treatment of inflammatory disease such as arthritis. New Zealand, Industrial Research Ltd.; 1998.
43. van den Berg WB: The role of cytokines and growth factors in cartilage destruction In osteoarthritis and rheumatoid arthritis. Zeitschrift fur Rheumatologie 1999, 58:136-141.
44. Wilmore DW, Shabert JK: Role of glutamine in immunologic responses. Nutrition 1998, 14:618-626.
45. Lemire J: 1,25-Dihydroxyvitamin D3 - a hormone with immunomodulatory properties. Zeitschrift fur Rheumatologie 2000, 59:24-27.
46. Halpern GM: Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol (Paris) 2000, 32:272-278.
47. Tenikoff D, Murphy KJ, Le M, Howe PR, Howarth GS: Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol 2005, 40:361-365.
48. Cho SH, Jung YB, Seong SC, Park HB, Byun KY, Lee DC, Song EK, Son JH: Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Allerg Immunol (Paris) 2003, 35:212-216.
49. Gibson SL: The effect of a lipid extract of the New Zealand green-lipped mussel in three cases of arthritis. J Altern Complement Med 2000, 6:351-354.
50. Bierer TL, Bui LM: Improvement of arthritic signs In dogs fed green-lipped mussel (Perna canaliculus). J Nutr 2002, 132: 1634S-6S.
51. Bui LM, Bierer TL: Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. Vet Ther 2003, 4:397-407.
52. Hill N, Sarvetnick N: Cytokines: promoters and dampeners of autoimmunity. Curr Opin Immunol 2002, 14:791-797.
53. Hoozemans JJ, O'Banion MK: The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs. Curr Drug Targets CNS Neurol Disord 2005, 4:307-315.